PUTTINI, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 1.268
EU - Europa 556
AS - Asia 186
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 2.016
Nazione #
US - Stati Uniti d'America 1.247
DE - Germania 149
CN - Cina 99
SE - Svezia 77
IT - Italia 72
UA - Ucraina 72
IE - Irlanda 68
SG - Singapore 49
GB - Regno Unito 28
RU - Federazione Russa 26
CA - Canada 21
HK - Hong Kong 19
BE - Belgio 16
DK - Danimarca 15
FI - Finlandia 15
IN - India 12
NL - Olanda 4
IR - Iran 3
RO - Romania 3
AT - Austria 2
EU - Europa 2
FR - Francia 2
TR - Turchia 2
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
LU - Lussemburgo 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
Totale 2.016
Città #
Ann Arbor 370
Woodbridge 134
Chandler 96
Fairfield 92
Wilmington 85
Frankfurt am Main 80
Dublin 65
Jacksonville 60
Ashburn 58
Houston 48
Dearborn 44
Seattle 33
Singapore 33
Milan 31
New York 27
Cambridge 23
Nanjing 23
Princeton 20
Göttingen 18
Hong Kong 18
Brussels 16
Shanghai 16
Lachine 10
Fremont 9
Guangzhou 9
Altamura 8
Lawrence 8
Nanchang 8
Shenyang 8
Beijing 6
Fürstenwalde 6
Pune 6
Santa Clara 6
Tianjin 6
Bari 5
Edmonton 5
Helsinki 5
Kiev 5
Toronto 5
Gorgonzola 4
Jinan 4
Kunming 4
London 4
Andover 3
Boardman 3
Dallas 3
Jiaxing 3
Munich 3
Changsha 2
Falls Church 2
Hefei 2
Huizen 2
Langfang 2
Monmouth Junction 2
Mountain View 2
Nürnberg 2
Quartucciu 2
Redmond 2
Rovellasca 2
San Diego 2
Trieste 2
Zanjan 2
Adliswil 1
Americana 1
Amsterdam 1
Auckland 1
Belgrade 1
Buffalo 1
Cairo 1
Central 1
Chicago 1
Duncan 1
Hangzhou 1
Kuala Lumpur 1
Leawood 1
Levico Terme 1
Lisbon 1
Luxembourg 1
Madrid 1
Manila 1
Norwalk 1
Olomouc 1
Oslo 1
Otley 1
Ottawa 1
Perugia 1
Philadelphia 1
Piemonte 1
Ripalta Cremasca 1
Robbio 1
Sacramento 1
San Francisco 1
San Mateo 1
Stockholm 1
Trento 1
Walnut 1
Wuhan 1
Zhangzhou 1
Totale 1.600
Nome #
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 301
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 300
Imatinib long term effects study: three years of follow-up and assessment 261
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 259
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 229
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma 197
Oncogenic fusion tyrosine kinases as molecular targets for anti-cancer therapy 184
Inhibition of RET tyrosine kinase by SU5416 183
NPM/ALK co-localizes with, and phosphorylates PSF and other RNA-binding proteins 129
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 126
Totale 2.169
Categoria #
all - tutte 6.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.105


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020388 0 0 34 28 39 51 75 37 49 35 35 5
2020/2021446 13 21 56 49 47 100 40 49 47 19 2 3
2021/2022149 5 12 18 8 7 17 7 4 5 18 15 33
2022/2023325 32 98 37 30 16 39 0 24 14 1 15 19
2023/2024221 11 10 14 19 28 60 36 9 13 0 2 19
2024/202585 19 37 29 0 0 0 0 0 0 0 0 0
Totale 2.169